Antiphospholipid Syndrome

  • Abhishek PurohitEmail author
  • Mayank Kumar


Antiphospholipid syndrome (APS) is a prothrombotic condition with immune pathogenesis that is characterized by thrombosis in the venous or arterial vasculature and/or pregnancy morbidity, which occurs in the presence of persistent laboratory evidence of antiphospholipid antibodies (aPLs). aPLs are autoantibodies that target phospholipid-bound proteins, especially β2-glycoprotein I (β2-GPI). The presence of these antibodies is the defining feature of this syndrome; however, the mechanism by which aPLs cause a hypercoagulable state is not fully understood [1].


APS Lupus thrombosis 


  1. 1.
    Lim W. Antiphospholipid Syndrome. Hematology. 2013;2013:675–80.CrossRefGoogle Scholar
  2. 2.
    Arachchillage DRJ, Greaves M. The chequered history of the antiphospholipid syndrome. Br J Haematol. 2014;165:609–17.CrossRefGoogle Scholar
  3. 3.
    Deka R, Saxena R. Antiphospholipid syndrome – revisited. In: Purohit A, Bohra GK, editors. Haematology pearls 2017. Jodhpur: Haematology Update 2017; 2017. p. 207–19.Google Scholar
  4. 4.
    Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46:1019–27.CrossRefGoogle Scholar
  5. 5.
    Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295–306.CrossRefGoogle Scholar
  6. 6.
    Pengo V, Banzato A, Denas G, Jose SP, Bison E, et al. Correct laboratory approach to APS diagnosis and monitoring. Autoimmun Rev. 2013;12:832–4.CrossRefGoogle Scholar
  7. 7.
    Rand JH, Wolgast LR. Dos and don’ts in diagnosing antiphospholipid syndrome. Hematology. 2012;2012:455–9.PubMedGoogle Scholar
  8. 8.
    Bucciarelli S, Espinosa G, Cervera R. The CAPS Registry: morbidity and mortality of the catastrophic antiphospholipid syndrome. Lupus. 2009;18:905–12.CrossRefGoogle Scholar
  9. 9.
    Urbanus RT, de Groot PG. Antiphospholipid antibodies: we are not quite there yet. Blood Rev. 2011;25:97–106.CrossRefGoogle Scholar
  10. 10.
    Brouwer JL, Bijl M, Veeger NJ, Kluin-Nelemans HC, van der Meer J. The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus. Blood. 2004;104:143–8.CrossRefGoogle Scholar
  11. 11.
    Arad A, Proulle V, Furie RA, Furie BC, Furie B. β2-glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model. Blood. 2011;117:3453–9.CrossRefGoogle Scholar
  12. 12.
    de Laat B, Derksen RH, van Lummel M, Pennings MT, de Groot PG. Pathogenic anti-beta2-glycoprotein I antibodies recognize domain I of beta2-glycoprotein I only after a conformational change. Blood. 2006;107:1916–24.CrossRefGoogle Scholar
  13. 13.
    de Groot PG, Meijers JC. β(2)-Glycoprotein I: evolution, structure and function. J Thromb Haemost. 2011;9:1275–84.CrossRefGoogle Scholar
  14. 14.
    Canaud G, Bienaimé F, Tabarin F, Bataillon G, Seilhean D. Inhibition of the mTORC pathway in the antiphospholipid syndrome. N Engl J Med. 2014;371:303–12.CrossRefGoogle Scholar
  15. 15.
    Liestøl S, Sandset PM, Mowinckel MC, Wisløff F. Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants. J Thromb Haemost. 2007;5:2204–11.CrossRefGoogle Scholar
  16. 16.
    Dignat-George F, Camoin-Jau L, Sabatier F, Arnoux D, Anfosso F, et al. Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome. Thromb Haemost. 2004;91:667–73.CrossRefGoogle Scholar
  17. 17.
    Mok CC, Tang S, To C, Petri M. Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups. Arthritis Rheum. 2005;52:2774–82.CrossRefGoogle Scholar
  18. 18.
    Yetman DL, Kutteh WH. Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertil Steril. 1996;66:540–6.CrossRefGoogle Scholar
  19. 19.
    Pengo V, Ruffatti A, Legnani C, Gresele P, Barcellona D, et al. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J Thromb Haemost. 2010;8:237–42.CrossRefGoogle Scholar
  20. 20.
    Muscal E, Brey RL. Neurologic manifestations of the antiphospholipid syndrome: integrating molecular and clinical lessons. Curr Rheumatol Rep. 2008;10:67.CrossRefGoogle Scholar
  21. 21.
    Uthman I, Godeau B, Taher A, Khamashta M. The hematologic manifestations of the antiphospholipid syndrome. Blood Rev. 2008;22:187–94.CrossRefGoogle Scholar
  22. 22.
    Denas G, Jose SP, Bracco A, Zoppellaro G, Pengo V. Antiphospholipid syndrome and the heart: a case series and literature review. Autoimmun Rev. 2015;14:214–22.CrossRefGoogle Scholar
  23. 23.
    Francès C, Niang S, Laffitte E, Pelletier F, Costedoat N, et al. Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases. Arthritis Rheum. 2005;52:1785–93.CrossRefGoogle Scholar
  24. 24.
    Cervera R, Bucciarelli S, Plasin MA, Gómez-Puerta JA, Plaza J, et al. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the “CAPS Registry”. J Autoimmun. 2009;32:240–5.CrossRefGoogle Scholar
  25. 25.
    Hunt BJ. Pediatric antiphospholipid antibodies and antiphospholipid syndrome. Semin Thromb Hemost. 2008;34:274–81.CrossRefGoogle Scholar
  26. 26.
    Chaturvedi S, McCrae KR. The antiphospholipid syndrome: still an enigma. Hematology. 2015;2015:53–60.CrossRefGoogle Scholar
  27. 27.
    Lockwood CJ, Lockshin MD. Management of antiphospholipid syndrome in pregnant and postpartum women. In: Berghella V, Pisetsky DS, editors. UpToDate. Waltham: UpToDate; 2017.Google Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Department of PathologyAll India Institute of Medical SciencesJodhpurIndia

Personalised recommendations